Cytogenetic and Molecular Monitoring of Residual Disease in Chronic Myeloid Leukaemia

Publisher： Karger

E-ISSN： 1421-9662|107|2|64-75

ISSN： 0001-5792

Source： Acta Haematologica, Vol.107, Iss.2, 2002-03, pp. : 64-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytogenetic and Molecular Genetic Aspects of Chronic Myeloid Leukaemia

By  

Acta Haematologica, Vol. 108, Iss. 4, 2002-11 ,pp. : 180-202

Karger

Access to resources Recommend Favorite

Continuous Complete Hematological and Cytogenetic Remission with Molecular Minimal Residual Disease 9 Years after Discontinuation of Interferon-α in a Patient with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia

By  

Acta Haematologica, Vol. 115, Iss. 1-2, 2006-01 ,pp. : 109-112

Karger

Access to resources Recommend Favorite

Effect of Retinoic Acid Treatment on Cytogenetic Remission of Chronic Myeloid Leukaemia

By  

Acta Haematologica, Vol. 109, Iss. 2, 2003-03 ,pp. : 84-89

Karger

Access to resources Recommend Favorite

Cytogenetic and Molecular Genetic Evolution of Chronic Myeloid Leukemia

By  

Acta Haematologica, Vol. 107, Iss. 2, 2002-03 ,pp. : 76-94

Karger

Access to resources Recommend Favorite

Pathogenesis, Diagnosis and Monitoring of Residual Disease in Acute Promyelocytic Leukaemia

By  

Acta Haematologica, Vol. 112, Iss. 1-2, 2004-06 ,pp. : 55-67

Karger

Access to resources Recommend Favorite